Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is Rp 2.003.749,62, with a 24-hour trading volume of Rp 5,8B. The asset's market cap is Rp 4,94P, after moving 0.45% in the last day.
Tokenized Merck & Co Inc is trading at Rp 2.017.630,86, with a tokenized market cap of Rp 14,81B and a 24-hour trading volume of Rp 17,5B. The tokenized asset has moved -2.62% in the past 24 hours.